Biomarkers for assessing liver function

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/68 (2006.01)

Patent

CA 2662597

A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA): albumin ratio (IMAR) in the individual", thereby to assess liver function in the individual.

La présente invention concerne un procédé d'évaluation de la fonction hépatique chez un individu, lequel procédé comprend la détermination du taux de méthylarginine (telle que ADMA et/ou SDMA) et le rapport de l'albumine modifiée par l'ischémie (IMA) : taux d'albumine (IMAR) chez l'individu, afin ainsi d'évaluer la fonction hépatique chez l'individu.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers for assessing liver function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for assessing liver function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for assessing liver function will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1817412

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.